Barry E Greene Sage Therapeutics, Inc. (SAGE) insider trading activity

SAGE Quotes by TradingView

Barry E Greene is President and CEO of Sage Therapeutics, Inc.. Currently has a direct ownership of 85,067 shares of SAGE, which is worth approximately $517,207. The most recent transaction as insider was on Aug 05, 2024, when has been sold 12,273 shares (Common Stock) at a price of $8.96 per share, resulting in proceeds of $109,966. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 85.1K
81.22% 3M change
81.22% 12M change
Total Value Held $517,207

Barry E Greene Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 05 2024
SELL
Payment of exercise price or tax liability
$109,966 $8.96 p/Share
12,273 Reduced 12.61%
85,067 Common Stock
Aug 05 2024
BUY
Grant, award, or other acquisition
-
50,400 Added 34.11%
97,340 Common Stock
Nov 10 2022
BUY
Open market or private purchase
$499,959 $34.48 p/Share
14,500 Added 23.6%
46,940 Common Stock
Aug 05 2021
BUY
Open market or private purchase
$1,020,066 $43.15 p/Share
23,640 Added 42.15%
32,440 Common Stock
Jun 16 2021
BUY
Open market or private purchase
$495,616 $56.32 p/Share
8,800 Added 50.0%
8,800 Common Stock

Also insider at

KPTI
Karyopharm Therapeutics Inc. Healthcare
ACOR
ACORDA THERAPEUTICS INC Healthcare
Director
BEG

Barry E Greene

President and CEO
Newton, MA

Track Institutional and Insider Activities on SAGE

Follow Sage Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SAGE shares.

Notify only if

Insider Trading

Get notified when an Sage Therapeutics, Inc. insider buys or sells SAGE shares.

Notify only if

News

Receive news related to Sage Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SAGE